The Hindu Morning Digest, June 23, 2024
Students from various organisation protest over the NEET-UG and UGC-NET examinations issue outside Ministry of Education in New Delhi. | Photo Credit: SHASHI SHEKHAR KASHYAP NEET-PG postponed, CBI to probe…
Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets
Image for representational purposes only. | Photo Credit: The Hindu Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is…
Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech
Bharat Biotech International Ltd on Friday said its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in children and adolescents of 2-18 years age group in…
CEPI to provide up to $19.3 m to Bharat Biotech, others for development of ‘variant-proof’ Covid vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced a $200-million programme for the development of vaccines that provide broad protection against SARS-CoV-2 variants and other beta coronaviruses. CEPI…
SII to give free Covishield vials to pvt vaccination centres to compensate for price difference
A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India (SII) told the Centre on…
India’s mega Covid booster shot programme begins from today – Here’s all you need to know
A day before the Covid-19 booster shoot drive is rolled out, both major vaccine manufacturers went on to announce a massive price cut on their vaccines. The Covid-19 vaccines Covishied…
Indian drug regulator examining WHO move on Covaxin; may seek update from company
In the light of the World Health Organisation (WHO)’s move to suspend supply of Covaxin produced by Hyderabad- headquartered Bharat Biotech, through UN procurement agencies, those in the Indian vaccine…
WHO suspends Covaxin supply to UN agencies
The World Health Organization (WHO) has confirmed it has suspended the supply of Covaxin, produced by city-based Bharat Biotech, through UN procurement agencies and recommending to countries that received the…
Bharat Biotech, Biofabri tie-up for tuberculosis vaccine
Biofabri is a biopharmaceutical company of Zendal group based in Porriño, Spain, with the aim of researching, developing and manufacturing vaccines for humans. The vaccine would be manufactured and developed…
AIIMS Delhi to start booster dose trial of intranasal Covid vaccine from Friday
India is yet to approve the use of intranasal vaccine against COVID-19, BBV154 developed by the Hyderabad based company. The AIIMS will start the booster dose trial of Bharat Biotech’s…